InsiderClue
Insiders · Profile

Ballal Rahul D.

Director at AGIOS PHARMACEUTICALS · Director at Enliven Therapeutics. Filing since 14 Dec 2020. CIK 0001805097

AGIO AGIOS PHARMACEUTICALS, INC. Director · 2 trades ELVN Enliven Therapeutics, Inc. Director · 10 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AGIO AGIOS PHARMACEUTICALS, INC.
8 Nov 2024
Director
Sold on a plan
10,000
$581.91K
55.6%
AGIO AGIOS PHARMACEUTICALS, INC.
7 Nov 2024
Director
Sold on a plan
10,000
$535.24K
55.6%
ELVN Enliven Therapeutics, Inc.
8 Oct 2024
Director
Sold on a plan
10,420
$293.56K
31.8%
ELVN Enliven Therapeutics, Inc.
11 Apr 2024
Director
Sold on a plan
53,400
$1.28M
70.5%
ELVN Enliven Therapeutics, Inc.
10 Apr 2024
Director
Sold on a plan
13,600
$285.74K
37.8%
ELVN Enliven Therapeutics, Inc.
4 Apr 2024
Director
Sold on a plan
3,485
$66.73K
13.5%
ELVN Enliven Therapeutics, Inc.
1 Apr 2024
Director
Sold on a plan
3,237
$61.76K
12.7%
ELVN Enliven Therapeutics, Inc.
20 Mar 2024
Director
Sold on a plan
13,278
$254.46K
37.3%
ELVN Enliven Therapeutics, Inc.
22 Feb 2023
Chief Executive Officer
Sold, plan not stated
32,861
$153.13K
27.2%
ELVN Enliven Therapeutics, Inc.
30 Jan 2023
Chief Executive Officer
Sold, plan not stated
11,313
$44.23K
8.6%
ELVN Enliven Therapeutics, Inc.
17 Dec 2020
Chief Executive Officer
Sold, plan not stated
4,999
$124.98K
100%
ELVN Enliven Therapeutics, Inc.
14 Dec 2020
Chief Executive Officer
Sold, plan not stated
1
$25.00
100%
12 decisions on file.